---
title: "RENALYTIX PLC SPON ADS EACH REP 50 ORD (POST SPLIT) (RNLXY.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RNLXY.US/norm.md"
symbol: "RNLXY.US"
name: "RENALYTIX PLC SPON ADS EACH REP 50 ORD (POST SPLIT)"
parent: "https://longbridge.com/en/quote/RNLXY.US.md"
datetime: "2026-03-04T06:25:30.144Z"
locales:
  - [en](https://longbridge.com/en/quote/RNLXY.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RNLXY.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RNLXY.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/RNLXY.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/RNLXY.US/norm.md)


# RENALYTIX PLC SPON ADS EACH REP 50 ORD (POST SPLIT) (RNLXY.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1000 | -2.24 | -2.56 | -4.00 | -4.50 |
| ROE | 542.87% | 197.28% | 298.40% | 324.88% | 718.53% |
| Revenue | 1.25M | 522000.00 | 586000.00 | 535000.00 | 709000.00 |
| Net income | -8.61M | -4.73M | -7.07M | -7.74M | -8.48M |
| Operating income | -7.53M | -4.09M | -5.53M | -6.14M | -8.34M |
| Gross margin | 39.81% | 19.16% | 6.14% | -12.34% | 32.30% |
| Net margin | -688.25% | -905.75% | -1207.17% | -1447.29% | -1196.76% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 11.44M | 4.79M | 7.97M | 8.77M | 11.28M |
| Leverage | -8.36 | -0.4235 | -1.01 | -0.7892 | -1.42 |
| BVPS | -0.0083 | -3.41 | -2.54 | -4.63 | -3.98 |
| Turnover | 0.2548 | 0.1933 | 0.1186 | 0.0915 | 0.0894 |
| Cash & STI | 9.63M | 909000.00 | 4.68M | 4.70M | 5.62M |
| Inv & Rec | 417000.00 | - | - | - | - |
| LT assets | 187000.00 | 202000.00 | 216000.00 | 230000.00 | 678000.00 |
| Net debt | -1.42M | 7.34M | 3.85M | 4.71M | 2.87M |

## Cash Flow Statement (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -10.33M | -3.84M | -7.83M | -4.86M | -7.92M |
| Investing CF | 22000.00 | - | -1000.00 | -3000.00 | - |
| Financing CF | 15.04M | 23000.00 | 7.79M | 4.03M | -507000.00 |
| Free CF | -7.20M | -2.21M | -5.95M | -2.68M | -4.49M |
| OCF coverage | -297.27% | - | -782600.00% | -162066.67% | -1319.83% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | -1000.00 | -3000.00 | - |